Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury

Journal of Neurotrauma

Volumn 29, Issue 2, 2012, Pages 362-374

  Yu, Fengshan ^a,b   Wang, Zhifei ^a   Tchantchou, Flaubert ^b   Chiu, Chi Tso ^a   Zhang, Yumin ^b   Chuang, De Maw ^a,b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

GSK 3b; lithium; neuroinflammation; neuroprotection; traumatic brain injury

Indexed keywords

CYCLOOXYGENASE 2; GELATINASE B; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM; NEUROPROTECTIVE AGENT; SERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; BLOOD BRAIN BARRIER; CELL ACTIVATION; ENZYME INHIBITION; INFLAMMATION; MALE; MICROGLIA; MOTOR COORDINATION; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROINFLAMMATION; NEUROPROTECTION; NONHUMAN; OPEN FIELD TEST; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN INJURIES; DISEASE MODELS, ANIMAL; INFLAMMATION; LITHIUM COMPOUNDS; MALE; MENTAL DISORDERS; MICE; MICE, INBRED C57BL; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS;

EID: 84863012874     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2011.1942     Document Type: Article

References (59)

1. Adachi, M., Barrot, M., Autry, A.E., Theobald, D., and Mon-teggia, L.M. (2008). Selective loss of brain-derived neuro-trophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol. Psychiatry 63, 642-649. (Pubitemid 351329281)
2. Ahmad, M., Rose, M.E., Vagni, V., Griffith, R.P., Dixon, C.E., Kochanek, P.M., Hickey, R.W., and Graham, S.H. (2008). Ge-netic disruption of cyclooxygenase-2 does not improve histo-logical or behavioral outcome after traumatic brain injury in mice. J. Neurosci. Res. 86, 3605-3612.
3. Andreasson, K. (2010). Emerging roles of PGE2 receptors in models of neurological disease. Prostaglandins Other Lipid Mediat. 91, 104-112.
4. Beaulieu, J.M., Sotnikova, T.D., Yao, W.D., Kockeritz, L., Woodgett, J.R., Gainetdinov, R.R., and Caron, M.G. (2004). Lithium antagonizes dopamine-dependent behaviors medi-ated by an AKT/glycogen synthase kinase 3 signaling cas-cade. Proc. Natl. Acad. Sci. USA 101, 5099-5104. (Pubitemid 38469209)
5. Beurel, E., Michalek, S.M., and Jope, R.S. (2010). Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol. 31, 24-31.
6. Bijur, G.N., and Jope, R.S. (2000). Opposing actions of phos-phatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity. J. Neurochem. 75, 2401-2408.
7. Bramlett, H.M., and Dietrich, W.D. (2007). Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies. Prog. Brain Res. 161, 125-141. (Pubitemid 47017402)
8. Cernak, I., O'Connor, C., and Vink, R (2002). Inhibition of cy-clooxygenase 2 by nimesulide improves cognitive outcome more than motor outcome following diffuse traumatic brain injury in rats. Exp. Brain Res. 147, 193-199. (Pubitemid 35471799)
9. Chalecka-Franaszek, E., and Chuang, D.M. (1999). Lithium ac-tivates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc. Natl. Acad. Sci. USA 96, 8745-8750. (Pubitemid 29354862)
10. Cheng, T., Petraglia, A.L., Li, Z., Thiyagarajan, M., Zhong, Z., Wu, Z., Liu, D., Maggirwar, S.B., Deane, R., Fernandez, J.A., LaRue, B., Griffin, J.H., Chopp, M., and Zlokovic, B.V. (2006). Activated protein C inhibits tissue plasminogen ac-tivator-induced brain hemorrhage. Nat. Med. 12, 1278-1285. (Pubitemid 44706930)
11. Chiu, C.T., and Chuang, D.M. (2010). Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol. Ther. 128, 281-304.
12. Chuang, D.M., and Manji, H.K. (2007). In search of the Holy Grail for the treatment of neurodegenerative disorders: has a simple cation been overlooked? Biol. Psychiatry 62, 4-6. (Pubitemid 46898231)
13. Clausen, F., Hanell, A., Bjork, M., Hillered, L., Mir, A.K., Gram, H., and Marklund, N. (2009). Neutralization of interleukin-1beta modifies the inflammatory response and improves his-tological and cognitive outcome following traumatic brain injury in mice. Eur. J. Neurosci. 30, 385-396.
14. Dash, P.K., Orsi, S.A., Zhang, M., Grill, R.J., Pati, S., Zhao, J., and Moore, A.N (2010). Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats. PLoS One 5, e11383.
15. Faul, M., Xu, L., Wald, M.M., and Coronado, V.G. (2010). Traumatic brain injury in the United States: emergency de-partment visits, hospitalization, and deaths. Centers for Dis-ease Control and Prevention, National Center for Injury Prevention and Control: Atlanta.
16. Fox, G.B., Fan, L., Levasseur, R.A., and Faden, A.I. (1998). Sus-tained sensory/motor and cognitive deficits with neuronal apoptosis following controlled cortical impact brain injury in the mouse. J. Neurotrauma 15, 599-614. (Pubitemid 28413053)
17. Fujimoto, S.T., Longhi, L., Saatman, K.E., Conte, V., Stocchetti, N., and McIntosh, T.K. (2004). Motor and cognitive function evaluation following experimental traumatic brain injury. Neurosci. Biobehav. Rev. 28, 365-378. (Pubitemid 39077928)
18. Gao, X., Deng-Bryant, Y., Cho, W., Carrico, K.M., Hall, E.D., and Chen, J. (2008). Selective death of newborn neurons in hip-pocampal dentate gyrus following moderate experimental traumatic brain injury. J. Neurosci. Res. 86, 2258-2270.
19. Hall, E.D., Bryant, Y.D., Cho, W., and Sullivan, P.G. (2008). Evolution of post-traumatic neurodegeneration after con-trolled cortical impact traumatic brain injury in mice and rats as assessed by the de Olmos silver and fluorojade staining methods. J. Neurotrauma 25, 235-247. (Pubitemid 351416738)
20. Hall, E.D., Vaishnav, R.A., and Mustafa, A.G. (2010). Anti- oxidant therapies for traumatic brain injury. Neurother- apeutics 7, 51-61.
21. Jope, R.S. (1999). Anti-bipolar therapy: mechanism of action of lithium. Mol. Psychiatry 4, 117-128. (Pubitemid 29163975)
22. Jope, R.S. (2003). Lithium and GSK-3: one inhibitor, two inhibi- tory actions, multiple outcomes. Trends Pharmacol. Sci. 24, 441-443. (Pubitemid 37088166)
23. Kelso, M.L., Scheff, S.W., Pauly, J.R., and Loftin, C.D. (2009). Effects of genetic deficiency of cyclooxygenase-1 or cyclooxygenase-2 on functional and histological outcomes following traumatic brain injury in mice. BMC Neurosci. 10, 108.
24. Kim, H.J., Rowe, M., Ren, M., Hong, J.S., Chen, P.S., and Chuang, D.M. (2007). Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat per- manent ischemic model of stroke: multiple mechanisms of action. J. Pharmacol. Exp. Ther. 321, 892-901. (Pubitemid 46762687)
25. Kirshenboim, N., Plotkin, B., Shlomo, S.B., Kaidanovich-Beilin, O., and Eldar-Finkelman, H. (2004). Lithium-mediated phos- phorylation of glycogen synthase kinase-3beta involves PI3 kinase-dependent activation of protein kinase C-alpha. J. Mol. Neurosci. 24, 237-245. (Pubitemid 41359151)
26. Klein, P.S., and Melton, D.A. (1996). A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA 93, 8455-8459. (Pubitemid 26269579)
27. Koh, S.H., Yoo, A.R., Chang, D.I., Hwang, S.J., and Kim, S.H. (2008). Inhibition of GSK-3 reduces infarct volume and im- proves neurobehavioral functions. Biochem. Biophys. Res. Commun. 371, 894-899.
28. Kunz, T., Marklund, N., Hillered, L., and Oliw, E.H. (2002). Cyclooxygenase-2, prostaglandin synthases, and prostaglan- din H2 metabolism in traumatic brain injury in the rat. J. Neurotrauma 19, 1051-1064.
29. Kunz, T., Marklund, N., Hillered, L., and Oliw, E.H. (2006). Effects of the selective cyclooxygenase-2 inhibitor rofecoxib on cell death following traumatic brain injury in the rat. Restor. Neurol. Neurosci. 24, 55-63.
30. Liang, M.H., and Chuang, D.M. (2006). Differential roles of glycogen synthase kinase-3 isoforms in the regulation of transcriptional activation. J. Biol. Chem. 281, 30479-30484.
31. Liang, M.H., and Chuang, D.M. (2007). Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival. J. Biol. Chem. 282, 3904-3917.
32. Loane, D.J., and Faden, A.I. (2010). Neuroprotection for traumatic brain injury: translational challenges and emerg- ing therapeutic strategies. Trends Pharmacol. Sci. 31, 596- 604.
33. Loane, D.J., Pocivavsek, A., Moussa, C.E., Thompson, R., Mat- suoka, Y., Faden, A.I., Rebeck, G.W., and Burns, M.P. (2009). Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury. Nat. Med. 15, 377-379.
34. Lotocki, G., Vaccari, J.P., Perez, E.R., Sanchez-Molano, J., Fur- ones-Alonso, O., Bramlett, H.M., and Dietrich, W.D. (2009). Alterations in blood-brain barrier permeability to large and small molecules and leukocyte accumulation after traumatic brain injury: effects of post-traumatic hypothermia. J. Neurotrauma 26, 1123-1134.
35. Li, X., and Jope, R.S. (2010). Is glycogen synthase kinase-3 a central modulator in mood regulation? Neuropsycho- pharmacology 35, 2143-2154.
36. Maas, A.I., Stocchetti, N., and Bullock, R (2008). Moderate and severe traumatic brain injury in adults. Lancet Neurol. 7, 728-741. (Pubitemid 351957931)
37. Margulies, S., and Hicks, R. (2009). Combination therapies for traumatic brain injury: prospective considerations. J. Neuro-trauma 26, 925-939.
38. Niwa, K., Araki, E., Morham, SG., Ross, M.E., and Iadecola, C. (2000). Cyclooxygenase-2 contributes to functional hyperemia in whisker-barrel cortex. J. Neurosci. 20, 763-770. (Pubitemid 30225578)
39. Nonaka, S., and Chuang, D.M. (1998). Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats. Neuroreport 9, 2081-2084. (Pubitemid 28300570)
40. Omata, N., Chiu, C.T., Moya, P.R., Leng, Y., Wang, Z., Huns-berger, J.G., Leeds, P., and Chuang, D.M. (2011). Lentivirally mediated GSK-3beta silencing in the hippocampal dentate gyrus induces antidepressant-like effects in stressed mice. Int. J. Neuropsychopharmacol. 14, 711-717.
41. Pandey, D.K., Yadav, S.K., Mahesh, R., and Rajkumar, R. (2009). Depression-like and anxiety-like behavioural aftermaths of impact accelerated traumatic brain injury in rats: a model of comorbid depression and anxiety? Behav. Brain Res. 205,436-442.
42. Prut, L., and Belzung, C. (2003). The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a re-view. Eur. J. Pharmacol. 463, 3-33. (Pubitemid 36205070)
43. Quiroz, J.A., Machado-Vieira, R., Zarate, C.A., Jr., and Manji, H.K. (2010). Novel insights into lithium's mechanism of ac-tion: neurotrophic and neuroprotective effects. Neuropsycho-biology 62, 50-60.
44. Ren, M., Senatorov, V.V., Chen, R.W., and Chuang, D.M. (2003). Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model. Proc. Natl. Acad. Sci. USA 100, 6210-6215. (Pubitemid 36576955)
45. Rosell, A., Cuadrado, E., Ortega-Aznar, A., Hernandez-Guilla-mon, M., Lo, E.H., and Montaner, J. (2008). MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke 39, 1121-1126. (Pubitemid 351440679)
46. Rowe, M.K., Wiest, C., and Chuang, D.M. (2007). GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder. Neurosci. Biobehav. Rev. 31, 920-931. (Pubitemid 47285347)
47. Sassi, R.B., Nicoletti, M., Brambilla, P., Mallinger, A.G., Frank, E., Kupfer, D.J., Keshavan, M.S., and Soares, J.C. (2002). In-creased gray matter volume in lithium-treated bipolar disor-der patients. Neurosci. Lett. 329, 243-245. (Pubitemid 34880083)
48. Senatorov, V.V., Ren, M., Kanai, H., Wei, H., and Chuang, D.M. (2004). Short-term lithium treatment promotes neuronal sur-vival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease. Mol. Psychiatry 9, 371-385. (Pubitemid 38534698)
49. Shapira, M., Licht, A., Milman, A., Pick, C.G., Shohami, E., and Eldar-Finkelman, H. (2007). Role of glycogen synthase kinase-3beta in early depressive behavior induced by mild traumatic brain injury. Mol. Cell. Neurosci. 34, 571-577. (Pubitemid 46483079)
50. Shein, N.A., Grigoriadis, N., Alexandrovich, A.G., Simeonidou, C., Lourbopoulos, A., Polyzoidou, E., Trembovler, V., Mas-cagni, P., Dinarello, C.A., and Shohami, E. (2009). Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury. FASEB J. 23, 4266-4275.
51. Shlosberg, D., Benifla, M., Kaufer, D., and Friedman, A. (2010). Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat. Rev. Neurol. 6, 393-403.
52. Van den Steen, P.E., Dubois, B., Nelissen, I., Rudd, P.M., Dwek, R.A., and Opdenakker, G. (2002). Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 37, 375-536. (Pubitemid 36071972)
53. Walker, C.T., Marky, A.H., Petraglia, A.L., Ali, T., Chow, N., and Zlokovic, B.V. (2010). Activated protein C analog with re-duced anticoagulant activity improves functional recovery and reduces bleeding risk following controlled cortical impact. Brain Res 1347, 125-131.
54. Wang, Z., Leng, Y., Tsai, L.K., Leeds, P., and Chuang, D.M. (2011). Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition. J. Cereb. Blood Flow Metab. 31, 52-57.
55. Yasuda, S., Liang, M.H., Marinova, Z., Yahyavi, A., and Chuang, D.M. (2009). The mood stabilizers lithium and valproate se-lectively activate the promoter IV of brain-derived neuro-trophic factor in neurons. Mol. Psychiatry 14, 51-59.
56. Yu, F., Kamada, H., Niizuma, K., Endo, H., and Chan, P.H. (2008). Induction of mmp-9 expression and endothelial injury by oxidative stress after spinal cord injury. J. Neurotrauma 25, 184-195. (Pubitemid 351416743)
57. Yu, I., Inaji, M., Maeda, J., Okauchi, T., Nariai, T., Ohno, K., Higuchi, M., and Suhara, T. (2010). Glial cell-mediated dete-rioration and repair of the nervous system after traumatic brain injury in a rat model as assessed by positron emission tomography. J. Neurotrauma 27, 1463-1475.
58. Yuskaitis, C.J., and Jope, R.S. (2009). Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflamma-tion-induced neurotoxicity. Cell Signal. 21, 264-273.
59. Zhu, Z.F., Wang, Q.G., Han, B.J., and William, C.P. (2010). Neu-roprotective effect and cognitive outcome of chronic lithium on traumatic brain injury in mice. Brain Res. Bull. 83, 272-277